Previous studies have found that clearing SnCs is associated with reduced AD pathology (i.e., tau protein and Aβ deposition), reduced SASP and inflammation, reduced white matter hypersignaling, restoration of cerebral blood flow, and improvement in cognitive behavior [21]. Here, MAPT is linked to Alzheimer disease.